Actuate Therapeutics, Inc. financial statements
Actuate Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 22.23M | 10-K |
| Cash and equivalents | USD 13.16M | 10-K |
| Total debt | USD 404.99K | EODHD |
Actuate Therapeutics, Inc. financials on 6ix · Actuate Therapeutics, Inc. on 6ix